---
figid: PMC4813390__BPH-173-003-g003
figtitle: Influence of TGFB‐SMAD and TGFB‐TAK1 signalling on adrenoceptor‐mediated
  pathways in LV heart failure progression
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4813390
filename: BPH-173-003-g003.jpg
figlink: /pmc/articles/PMC4813390/figure/bph13344-fig-0003/
number: F3
caption: Influence of TGFβ‐SMAD and TGFβ‐TAK1 signalling on adrenoceptor‐mediated
  pathways in LV heart failure progression. Adrenoceptors (AR) stimulate the expression
  of genes promoting hypertrophic growth via the transcription factor AP‐1. Under
  simultaneous presence of SMAD4, the pro‐hypertrophic response to adrenoceptor stimulation
  is shifted to a pro‐apoptotic gene transcription via AP‐1/SMAD complexes. Also,
  under TGFβ stimulation of cardiomyocytes, AP‐1 and SMADs mediate apoptosis. In addition
  to these effects on cardiomyocytes, activation of the TGFβ/SMAD pathway or induction
  of SMADs via β‐arrestins induces the transcription of fibrotic genes. In contrast
  to the SMAD pathway, TAK1 activation stimulates hypertrophic growth while inhibiting
  cardiac necroptosis and apoptosis by interacting with RIP1. Strong β‐adrenoceptor
  (ADRB) activation results in β‐adrenoceptor desensitization via β‐adrenoceptor /β‐arrestin
  complexes. This process can be inhibited by TGFβ. Depicted in red are switch molecules
  that can modulate the response of the cell to receptor stimulation and thereby influence
  the outcome of this stimulation on the remodelling process.
papertitle: Molecular switches under TGFβ signalling during progression from cardiac
  hypertrophy to heart failure.
reftext: J Heger, et al. Br J Pharmacol. 2016 Jan;173(1):3-14.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.959959
figid_alias: PMC4813390__F3
figtype: Figure
redirect_from: /figures/PMC4813390__F3
ndex: e85bb948-dedf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4813390__BPH-173-003-g003.html
  '@type': Dataset
  description: Influence of TGFβ‐SMAD and TGFβ‐TAK1 signalling on adrenoceptor‐mediated
    pathways in LV heart failure progression. Adrenoceptors (AR) stimulate the expression
    of genes promoting hypertrophic growth via the transcription factor AP‐1. Under
    simultaneous presence of SMAD4, the pro‐hypertrophic response to adrenoceptor
    stimulation is shifted to a pro‐apoptotic gene transcription via AP‐1/SMAD complexes.
    Also, under TGFβ stimulation of cardiomyocytes, AP‐1 and SMADs mediate apoptosis.
    In addition to these effects on cardiomyocytes, activation of the TGFβ/SMAD pathway
    or induction of SMADs via β‐arrestins induces the transcription of fibrotic genes.
    In contrast to the SMAD pathway, TAK1 activation stimulates hypertrophic growth
    while inhibiting cardiac necroptosis and apoptosis by interacting with RIP1. Strong
    β‐adrenoceptor (ADRB) activation results in β‐adrenoceptor desensitization via
    β‐adrenoceptor /β‐arrestin complexes. This process can be inhibited by TGFβ. Depicted
    in red are switch molecules that can modulate the response of the cell to receptor
    stimulation and thereby influence the outcome of this stimulation on the remodelling
    process.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - pe
  - Ne
  - egr
  - dpp
  - gbb
  - put
  - mav
  - ar
  - Smox
  - Mad
  - Tak1
  - Med
  - AP-1gamma
  - Jra
  - kay
  - TNF
  - TGFB1
  - TGFB2
  - TGFB3
  - ADRB1
  - ADRB2
  - ADRB3
  - AR
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - UQCRFS1
  - RIPK1
  - RALBP1
  - KRR1
  - MAP3K7
  - NR2C2
  - TGFBR2
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - TGFBR1
---
